Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07447635

Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors

Smoking Cessation and Alcohol Use Among Cancer Survivors: Investigating the Efficacy of a Mindfulness-Based Intervention

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
600 (estimated)
Sponsor
H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study will examine the efficacy of Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) compared to standard care among cancer survivors who smoke cigarettes and engage in at-risk alcohol use. Investigators will evaluate implementation outcomes through structured stakeholder interviews across medical centers, cancer-focused organizations, and community-based programs in Florida, and will conduct a cost-assessment and an incremental cost-effectiveness analysis of the two conditions.

Detailed description

The primary aim of this study is to test the efficacy of MBRP-SA compared with standard care among cancer survivors, explore potential moderators, mechanisms, and predictors of treatment effects, and evaluate implementation outcomes to guide future adoption of MBRP-SA.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA)MBRP-SA is a nine-week, group-based mindfulness program designed to help cancer survivors quit smoking and reduce heavy alcohol use by targeting craving, stress, and habitual behavior patterns. Participants will also receive 10 weeks of nicotine replacement therapy.
BEHAVIORALQuitline SupportParticipants will be connected to the Florida Tobacco Quitline, which provides standard evidence-based smoking cessation support, including phone-based counseling, web-based resources, and access to text-messaging programs. The Quitline also offers up to a four-week supply of nicotine replacement therapy (patches, gum, or lozenges). Participants will also receive referrals to various alcohol-related treatment options in the community.

Timeline

Start date
2026-02-01
Primary completion
2029-12-01
Completion
2029-12-01
First posted
2026-03-03
Last updated
2026-03-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07447635. Inclusion in this directory is not an endorsement.